Stock AnalizOmega Healthcare Investors (OHI) earnings for the quarter ended September 2026: EPS beats estimates
Omega Healthcare Investors reported results for the quarter ended September 2026 on November 3, 2026. Adjusted earnings per share came in at $0.50 against the analysts’ average forecast of $0.48, a beat of 5.2%.
Revenue for the quarter was $341 million, up 9.3% from $312 million in the same quarter a year earlier.
The market’s verdict: the stock rose 4.6% on the first trading day after the report.
The last four quarters
Omega Healthcare Investors has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.50 | $0.48 | +5.2% | +9% | +4.6% |
| Jun 2026 | $1.22 | $0.48 | +154.3% | +16% | −2.4% |
| Mar 2026 | $0.48 | $0.49 | −3.8% | +17% | +0.1% |
| Dec 2025 | $0.53 | $0.50 | +5.2% | +14% | +6.2% |
What comes next
Analysts expect EPS of $0.39 for the next quarter on average and $2.53 for the fiscal year ending December 31, 2026.
The average analyst price target is $51.68, 10% above the current price of $47.05.
Valuation and score
Omega Healthcare Investors scores 3.0 out of 5 overall on Stock Analiz (good, with some weak spots), trades at a trailing P/E of about 19.0, and its intrinsic value under moderate assumptions is about 49% below the current market value. Full Omega Healthcare Investors analysis with 10 years of financials
Frequently asked questions
What was Omega Healthcare Investors’s EPS for the quarter ended September 2026?
$0.50 adjusted per share, against an analyst consensus of $0.48.
How much revenue did Omega Healthcare Investors report?
$341 million, up 9.3% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.